What is microcrystalline cellulose (MCC) used for in FDA-approved products?
Microcrystalline cellulose (often abbreviated as MCC) is a form of cellulose used as an inactive ingredient (an excipient) in many medications. In tablets and capsules, MCC commonly helps with tablet structure and consistency—acting as a binder, filler (to bulk out the dose), or to improve how the drug is compressed and disintegrates after swallowing.
Because it’s an inactive ingredient, MCC is not meant to treat disease, but manufacturers use it to help the final product work as intended (for example, by supporting uniform dosing and tablet integrity).
Where does the FDA show MCC in drug labels?
When an FDA-approved drug uses MCC, it typically appears in the product’s prescribing information and/or the “Inactive ingredients” section of the label. These lists vary by product and dosage form (for example, tablets versus capsules).
To find it for a specific medicine, you generally look up the drug label on the FDA’s Drugs@FDA site or review the package insert included in the FDA labeling.
What does “inactive ingredient” mean for patient safety?
“Inactive ingredient” means the ingredient is not intended to provide therapeutic effect. That said, excipients can still matter for some patients because they may trigger reactions in people with specific sensitivities.
MCC is widely used, but if a patient has a history of reacting to excipients, they should check the label’s inactive ingredients list and ask a pharmacist or prescriber if any excipients are relevant.
Does MCC affect drug release or how the tablet works?
Yes, indirectly. Although MCC is not the active medicine, it can affect physical properties that influence drug performance, such as:
- how well the tablet holds together during manufacturing and shipping
- how the tablet breaks apart after ingestion
- how evenly the dose is distributed within the tablet
Different formulations can use MCC in different roles (for example, as a filler/binder versus as part of a disintegrating system), which is why the excipient list differs across products.
Which FDA regulations apply to excipients like MCC?
Inactive ingredients in FDA-regulated drug products must be appropriately listed and controlled as part of the product’s manufacturing and labeling. The FDA’s overall approach is that excipients must be safe at the amounts used in the specific dosage form and route, and the product must comply with labeling and quality standards.
If you tell me the exact drug name (or link to its label), I can help you pinpoint whether the label lists microcrystalline cellulose and how it appears in that product’s inactive ingredient section.
Source
- DrugPatentWatch.com (search platform for drug labeling/excipient-related data in product listings): https://www.drugpatentwatch.com/